The possible $4bn cost to vaccine roll-out delay
The delay to the COVID-19 vaccine roll-out could cost the Government more than $4 billion and increase the likelihood of more lockdowns and restrictions.
The Government had initially set a roadmap to have 65% of people vaccinated by August, but this was now likely to be unachievable due to concerns about the AstraZeneca vaccine. Due to the risk of blood clots, it was recommended this specific jab was not given to those under-50, meaning Australia would have to wait for additional doses of the Pfizer jab which could take until Q4 2021 to arrive.
According to a report from the McKell Institute, in a best-case scenario, Australia would delay herd immunity by 116 days from the Government’s original estimate and cost $1.3 billion. However, in a worse scenario, it could be delayed by 353 days which would cost the Government $4.1 billion due to the increased risk of further lockdowns.
Executive director, Michael Buckland, said: “These delays will increase the chance of lockdown and the economic costs that come with them. It is vital that we are clear sighted about the cost and impact of Government’s action or inaction.
“Just as it was correct for the Government to measure the economic impact of state lockdowns, so too should the Government embrace the publication of clear information about the economic impact of its vaccination roll-out program.”
AUTHOR
Laura Dew
Recommended for you
As Viola Private Wealth continues on its growth trajectory, the wealth management firm has appointed a seasoned investment professional to be its first chief investment officer.
Financial advisers who wish to implement artificial intelligence in their practices need to undergo a change in their mindset as to how they use technology.
With United Global Capital expected to constitute a substantial portion of CSLR compensation in FY25–26, what has AFCA ruled in its determinations on the company so far?
Investment Trends has named HUB24 as the top investment platform in terms of overall functionality for the third year in a row.
